by David Wallace
Patients are Asking - Episode 2 of 3
In this interview with MPN expert, Dr. Angela Fleischman, we discuss the latest treatments for myelofibrosis (MF) and when a clinical trial should be considered.
Research has linked MPNs to a pre-disposition to autoimmune disorders such as Lupus, Crohn's disease and Psoriasis just to name a few. Keep watching to learn why this occurs.
Discover the latest on a clinical trial for N-Acetylcysteine (NAC) in patients with myeloproliferative neoplasms. We have published research on NAC and remain hopeful on its usefulness.
Featuring: Dr. Angela Fleischman
Thank you to our Sponsors
![PharmaEssentia logo PharmaEssentia Logo](https://i0.wp.com/www.pvreporter.com/wp-content/uploads/2019/11/PharmaEssentia-logo-e1624289226747.jpg?resize=151%2C29&ssl=1)
![Print Abbvie logo](https://i0.wp.com/www.pvreporter.com/wp-content/uploads/2021/10/AbbVieLogo_Small_UncoatedPMS.jpg?resize=300%2C53&ssl=1)
![bristol-myers-squibb-1 bristol-myers-squibb-1](https://i0.wp.com/www.pvreporter.com/wp-content/uploads/2022/10/bristol-myers-squibb-1-1.png?resize=413%2C68&ssl=1)